Trellus Health (TRLS) Competitors GBX 0.80 +0.09 (+13.31%) As of 03:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHCShould you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry. Trellus Health vs. Its Competitors IQ-AI DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition Induction Healthcare Group IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations. Do institutionals and insiders have more ownership in IQAI or TRLS? 5.8% of Trellus Health shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by company insiders. Comparatively, 21.5% of Trellus Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor IQAI or TRLS? In the previous week, IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score. Company Overall Sentiment IQ-AI Neutral Trellus Health Neutral Which has more risk and volatility, IQAI or TRLS? IQ-AI has a beta of 2.25, indicating that its share price is 125% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Is IQAI or TRLS more profitable? IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets IQ-AI-77.52% -140.75% -22.03% Trellus Health -12,114.55%-37.95%-22.76% Which has stronger valuation & earnings, IQAI or TRLS? IQ-AI has higher revenue and earnings than Trellus Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIQ-AI£538.19K3.30N/AN/AN/ATrellus Health£359K3.60-£7.98M-£0.05-16.00 SummaryIQ-AI beats Trellus Health on 6 of the 9 factors compared between the two stocks. Get Trellus Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRLS vs. The Competition Export to ExcelMetricTrellus HealthHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£1.29M£379.02M£6.11B£2.60BDividend YieldN/A5.89%5.66%5.30%P/E Ratio-16.00531.1186.934,478.44Price / Sales3.60229.40529.8899,502.99Price / Cash0.7647.1426.3027.90Price / Book0.085.2312.748.25Net Income-£7.98M-£15.55M£3.30B£5.89B7 Day Performance32.01%2.23%3.55%1.56%1 Month Performance1.27%6.25%6.79%6.83%1 Year Performance-15.79%13.35%73.23%155.61% Trellus Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRLSTrellus HealthN/AGBX 0.80+13.3%N/A-25.7%£1.29M£359K-16.0031Gap DownIQAIIQ-AIN/AGBX 0.80flatN/A-27.3%£1.77M£538.19K-13.676Gap UpDVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583K£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware2.1692 of 5 starsGBX 2,330+2.6%GBX 2,873.67+23.3%+17.2%£825.05M£205.66M5,482.35734Gap UpINSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500KOOKooth1.5093 of 5 starsGBX 140.54-1.4%GBX 365+159.7%-55.5%£50.39M£66.74M669.24478Gap UpRENXRenalytixN/AGBX 9.54-4.6%N/A+9.5%£31.59M£2.37M-59.61102High Trading VolumeCOGCambridge CognitionN/AGBX 39-2.5%N/A+10.1%£17.93M£9.05M-1,026.3280INHCInduction Healthcare GroupN/AGBX 9.75flatN/AN/A£9.00M£12.57M-1.7674 Related Companies and Tools Related Companies IQAI Competitors DVRG Competitors SENS Competitors EMIS Competitors CRW Competitors INS Competitors KOO Competitors RENX Competitors COG Competitors INHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TRLS) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trellus Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
